LeadIQ logo
Learn more at LeadIQ.com
Oculis

Oculis Employee Directory

Biotechnology ResearchSwitzerland, Switzerland11-50 Employees

Oculis (Nasdaq: OCS) is a global biopharmaceutical company purposefully driven to save sight and improve eye care. Oculis’ highly differentiated clinical-stage pipeline comprises multiple innovative product candidates in development for eye diseases of high unmet need. It includes OCS-01 eye drops, a topical candidate in Phase 3 development for diabetic macular edema (DME) and inflammation and pain following ocular surgery; OCS-02 eye drops, a topical biologic candidate in Phase 2 development for dry eye disease (DED) and uveitis; and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophthalmic disorders, such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The first in-patient, proof-of-concept trial with OCS-05 is currently ongoing in France. Headquartered in Switzerland and with operations in the US, Europe, and China, Oculis’ goal is to deliver life-changing eye treatments to patients worldwide. The company is led by an experienced management team with a successful track record in the pharmaceutical industry, supported by leading international healthcare investors.

Find Oculis employees' phone numbers or email addresses

Oculis Global Highlights

Location
Employees

Europe
47

Minus sign iconPlus sign icon
  • Switzerland
    25
  • Iceland
    12
  • United Kingdom Of Great Britain And Northern Ireland
    5
  • Spain
    3
  • France
    1
  • Belgium
    1

North America
18

Minus sign iconPlus sign icon
  • United States Of America
    18

Asia
2

Minus sign iconPlus sign icon
  • Lebanon
    1
  • China
    1

Africa
1

Minus sign iconPlus sign icon
  • South Africa
    1

Oculis's Leadership

Contact profiles from Oculis

Name
Title
Contact Info
Location
Last Update

Frequently Asked Questions

What is Oculis known for?

Minus sign iconPlus sign icon
Oculis was founded in 2017 operates in the Biotechnology Research industry. The company's main headquarters is located in EPFL Innovation Park EPFL Innovation Park - Building D Lausanne, Switzerland 1015 CH. Explore Oculis's company overview page for more information.

What is Oculis's most common email format?

Minus sign iconPlus sign icon
Oculis employees' email format typically follows the pattern of . Trying to find reliable and up-to-date employee contact data? Find more Oculis email formats with LeadIQ.

How many employees does Oculis have currently?

Minus sign iconPlus sign icon
Oculis has approximately 45 employees as of September 2024. These team members are located across 4 continents, including EuropeNorth AmericaAsia.

Who are Oculis's key employees and leadership?

Minus sign iconPlus sign icon

As of September 2024, Oculis's key employees include:

  • Chief Scientific Officer: D. K.
  • Chief Technology Officer: G. B.
  • Chief Development Officer: B. D.
  • Chief Legal Officer: D. C.
  • Chief Strategy Officer: P. R. J.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.